Global Histone Deacetylase 1 Market Research Report 2026

Global Histone Deacetylase 1 Market Research Report 2026

Pages: 210

Format: PDF

Date: 01-2026

Global Histone Deacetylase 1 (HDAC1) Market

Industry Landscape, Segmentation, Competitive Analysis & Forecast (2026–2036)

Market Overview

The global Histone Deacetylase 1 (HDAC1) market is an emerging and highly specialized segment within the epigenetics and oncology therapeutics landscape. HDAC1 plays a critical role in chromatin remodeling and gene expression regulation, making it a key molecular target in cancer, neurological disorders, dermatological diseases, and hematologic malignancies.

In 2020, the global HDAC1 market was valued at XX million US$ and is expected to reach XX million US$ by 2036, expanding at a CAGR of XX% during the forecast period (2026–2036). Growth is primarily driven by increasing oncology drug pipelines, expanding epigenetic research, and rising investment in precision medicine.


Competitive Landscape – Key Market Players

The market is R&D-intensive and innovation-driven, dominated by pharmaceutical companies and biotech firms focusing on targeted epigenetic therapies.

Major Companies Profiled

  • 4SC AG

  • Acetylon Pharmaceuticals

  • Chipscreen Biosciences

  • Curis

  • GlaxoSmithKline

  • HitGen

  • IRBM Science Park

  • Italfarmaco

  • MEI Pharma

  • Merck & Co.

  • Mirati Therapeutics

  • Oncolys BioPharma

  • Sigma-Tau

  • Syndax Pharmaceuticals

  • TetraLogic Pharmaceuticals

Additional Emerging & Pipeline Participants

  • Selvita S.A.

  • Epizyme (epigenetics-focused oncology developer)

  • Beijing Kawin Technology

  • Ascentage Pharma

  • Haisco Pharmaceutical Group


Segmentation Analysis

By Product / Molecule Type

  • RCY-1305

  • HG-3001

  • CS-3158

  • ACY-957

  • ST-3595

  • Other HDAC1-Selective & Dual Inhibitors

Insight: Selective HDAC1 inhibitors are gaining preference over pan-HDAC inhibitors due to improved safety profiles and reduced off-target toxicity.


By Application

  • Alopecia

  • Endometrial Cancer

  • Myelofibrosis

  • Neurological Disorders

  • Skin Cancer

  • Other Oncological & Autoimmune Indications

Insight: Oncology applications account for the largest share, while neurology represents a high-growth emerging segment.


Regional Analysis

North America

  • Dominant market driven by strong clinical trial activity and advanced oncology infrastructure.

  • The United States leads in HDAC1 drug development and licensing activity.

Europe

  • Robust growth supported by academic-industry collaboration and regulatory support for orphan drugs.

  • Germany, France, and the UK are major contributors.

Asia-Pacific

  • Fastest-growing region due to rising cancer prevalence and expanding biotech ecosystems.

  • China and Japan lead in epigenetic research investment.

Central & South America

  • Gradual market expansion driven by improving oncology treatment access.

  • Brazil and Argentina are primary growth markets.

Middle East & Africa

  • Early-stage adoption with long-term growth potential as oncology infrastructure develops.


Porter’s Five Forces Analysis

  • Threat of New Entrants: Low – High R&D cost and regulatory complexity

  • Bargaining Power of Suppliers: Moderate – Specialized chemical and biotech inputs

  • Bargaining Power of Buyers: Low – Limited therapeutic substitutes

  • Threat of Substitutes: Low – HDAC1 targets are highly specific

  • Competitive Rivalry: High – Intense competition in oncology pipelines


SWOT Analysis

Strengths

  • Strong scientific rationale and clinical relevance

  • Growing precision oncology demand

  • High unmet medical needs

Weaknesses

  • Long development timelines

  • High clinical trial failure risk

Opportunities

  • Expansion into non-oncology indications

  • Combination therapies with immuno-oncology drugs

  • Licensing and co-development agreements

Threats

  • Regulatory delays

  • Safety concerns related to epigenetic modulation

  • Competition from next-generation gene therapies


Market Trends

  • Shift toward selective HDAC1 inhibitors

  • Rising number of combination oncology trials

  • Integration of AI-driven drug discovery

  • Increased focus on rare and orphan cancers


Market Drivers & Challenges

Key Drivers

  • Rising global cancer burden

  • Expansion of epigenetics-based drug discovery

  • Increased funding for targeted therapies

Key Challenges

  • High cost of drug development

  • Complex regulatory pathways

  • Limited long-term safety data


Value Chain Analysis

  1. Basic & Translational Epigenetic Research

  2. Drug Discovery & Lead Optimization

  3. Preclinical & Clinical Development

  4. Regulatory Approval

  5. Commercial Manufacturing

  6. Distribution & Oncology Care Providers


Strategic Recommendations for Stakeholders

  • Pharma Companies: Prioritize selective HDAC1 inhibitors with combination therapy potential

  • Biotech Firms: Leverage partnerships to accelerate clinical development

  • Investors: Focus on late-stage oncology pipelines and orphan drug designations

  • Research Institutes: Expand translational epigenetics programs

  • Healthcare Providers: Prepare for personalized epigenetic treatment protocols


Study Timeline

  • Historical Period: 2020–2024

  • Base Year: 2025

  • Estimated Year: 2026

  • Forecast Period: 2026–2036


Key Stakeholders

  • HDAC1 Drug Developers & Manufacturers

  • CROs & Research Institutes

  • Oncology Treatment Centers

  • Regulatory Authorities

  • Investors & Strategic Partners


Customization Options Available

  • Country-level and indication-specific market forecasts

  • Competitive pipeline benchmarking

  • Regulatory and clinical trial landscape analysis

  • Partnering & licensing opportunity assessment

Table of Contents

Global Histone Deacetylase 1 Sales Market Report 2018
1 Histone Deacetylase 1 Market Overview
    1.1 Product Overview and Scope of Histone Deacetylase 1
    1.2 Classification of Histone Deacetylase 1 by Product Category
        1.2.1 Global Histone Deacetylase 1 Market Size (Sales) Comparison by Type
        1.2.2 Global Histone Deacetylase 1 Market Size (Sales) Market Share by Type (Product Category) in
        1.2.3 RCY-1305
        1.2.4 HG-3001
        1.2.5 CS-3158
        1.2.6 ACY-957
        1.2.7 ST-3595
        1.2.8 Others
    1.3 Global Histone Deacetylase 1 Market by Application/End Users
        1.3.1 Global Histone Deacetylase 1 Sales (Volume) and Market Share Comparison by Application
        1.3.1 Alopecia
        1.3.2 Endometrial Cancer
        1.3.3 Myelofibrosis
        1.3.4 Neurology
        1.3.5 Skin Cancer
        1.3.6 Others
    1.4 Global Histone Deacetylase 1 Market by Region
        1.4.1 Global Histone Deacetylase 1 Market Size (Value) Comparison by Region
        1.4.2 United States Histone Deacetylase 1 Status and Prospect
        1.4.3 Europe Histone Deacetylase 1 Status and Prospect
        1.4.4 China Histone Deacetylase 1 Status and Prospect
        1.4.5 Japan Histone Deacetylase 1 Status and Prospect
        1.4.6 Southeast Asia Histone Deacetylase 1 Status and Prospect
        1.4.7 India Histone Deacetylase 1 Status and Prospect
    1.5 Global Market Size (Value and Volume) of Histone Deacetylase 1
        1.5.1 Global Histone Deacetylase 1 Sales and Growth Rate
        1.5.2 Global Histone Deacetylase 1 Revenue and Growth Rate

2 Global Histone Deacetylase 1 Competition by Players/Suppliers, Type and Application
     2.1 Global Histone Deacetylase 1 Market Competition by Players/Suppliers
        2.1.1 Global Histone Deacetylase 1 Sales and Market Share of Key Players/Suppliers ()
        2.1.2 Global Histone Deacetylase 1 Revenue and Share by Players/Suppliers ()
    2.2 Global Histone Deacetylase 1 (Volume and Value) by Type
        2.2.1 Global Histone Deacetylase 1 Sales and Market Share by Type ()
        2.2.2 Global Histone Deacetylase 1 Revenue and Market Share by Type ()
    2.3 Global Histone Deacetylase 1 (Volume and Value) by Region
        2.3.1 Global Histone Deacetylase 1 Sales and Market Share by Region ()
        2.3.2 Global Histone Deacetylase 1 Revenue and Market Share by Region ()
    2.4 Global Histone Deacetylase 1 (Volume) by Application

3 United States Histone Deacetylase 1 (Volume, Value and Sales Price)
    3.1 United States Histone Deacetylase 1 Sales and Value ()
        3.1.1 United States Histone Deacetylase 1 Sales and Growth Rate ()
        3.1.2 United States Histone Deacetylase 1 Revenue and Growth Rate ()
        3.1.3 United States Histone Deacetylase 1 Sales Price Trend ()
    3.2 United States Histone Deacetylase 1 Sales Volume and Market Share by Players ()
    3.3 United States Histone Deacetylase 1 Sales Volume and Market Share by Type ()
    3.4 United States Histone Deacetylase 1 Sales Volume and Market Share by Application ()

4 Europe Histone Deacetylase 1 (Volume, Value and Sales Price)
    4.1 Europe Histone Deacetylase 1 Sales and Value ()
        4.1.1 Europe Histone Deacetylase 1 Sales and Growth Rate ()
        4.1.2 Europe Histone Deacetylase 1 Revenue and Growth Rate ()
        4.1.3 Europe Histone Deacetylase 1 Sales Price Trend ()
    4.2 Europe Histone Deacetylase 1 Sales Volume and Market Share by Players ()
    4.3 Europe Histone Deacetylase 1 Sales Volume and Market Share by Type ()
    4.4 Europe Histone Deacetylase 1 Sales Volume and Market Share by Application ()

5 China Histone Deacetylase 1 (Volume, Value and Sales Price)
    5.1 China Histone Deacetylase 1 Sales and Value ()
        5.1.1 China Histone Deacetylase 1 Sales and Growth Rate ()
        5.1.2 China Histone Deacetylase 1 Revenue and Growth Rate ()
        5.1.3 China Histone Deacetylase 1 Sales Price Trend ()
    5.2 China Histone Deacetylase 1 Sales Volume and Market Share by Players ()
    5.3 China Histone Deacetylase 1 Sales Volume and Market Share by Type ()
    5.4 China Histone Deacetylase 1 Sales Volume and Market Share by Application ()

6 Japan Histone Deacetylase 1 (Volume, Value and Sales Price)
    6.1 Japan Histone Deacetylase 1 Sales and Value ()
        6.1.1 Japan Histone Deacetylase 1 Sales and Growth Rate ()
        6.1.2 Japan Histone Deacetylase 1 Revenue and Growth Rate ()
        6.1.3 Japan Histone Deacetylase 1 Sales Price Trend ()
    6.2 Japan Histone Deacetylase 1 Sales Volume and Market Share by Players ()
    6.3 Japan Histone Deacetylase 1 Sales Volume and Market Share by Type ()
    6.4 Japan Histone Deacetylase 1 Sales Volume and Market Share by Application ()

7 Southeast Asia Histone Deacetylase 1 (Volume, Value and Sales Price)
    7.1 Southeast Asia Histone Deacetylase 1 Sales and Value ()
        7.1.1 Southeast Asia Histone Deacetylase 1 Sales and Growth Rate ()
        7.1.2 Southeast Asia Histone Deacetylase 1 Revenue and Growth Rate ()
        7.1.3 Southeast Asia Histone Deacetylase 1 Sales Price Trend ()
    7.2 Southeast Asia Histone Deacetylase 1 Sales Volume and Market Share by Players ()
    7.3 Southeast Asia Histone Deacetylase 1 Sales Volume and Market Share by Type ()
    7.4 Southeast Asia Histone Deacetylase 1 Sales Volume and Market Share by Application ()

8 India Histone Deacetylase 1 (Volume, Value and Sales Price)
    8.1 India Histone Deacetylase 1 Sales and Value ()
        8.1.1 India Histone Deacetylase 1 Sales and Growth Rate ()
        8.1.2 India Histone Deacetylase 1 Revenue and Growth Rate ()
        8.1.3 India Histone Deacetylase 1 Sales Price Trend ()
    8.2 India Histone Deacetylase 1 Sales Volume and Market Share by Players ()
    8.3 India Histone Deacetylase 1 Sales Volume and Market Share by Type ()
    8.4 India Histone Deacetylase 1 Sales Volume and Market Share by Application ()

9 Global Histone Deacetylase 1 Players/Suppliers Profiles and Sales Data
    9.1 4SC AG
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Histone Deacetylase 1 Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 4SC AG Histone Deacetylase 1 Sales, Revenue, Price and Gross Margin ()
        9.1.4 Main Business/Business Overview
    9.2 Acetylon Pharmaceuticals, Inc.
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Histone Deacetylase 1 Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Sales, Revenue, Price and Gross Margin ()
        9.2.4 Main Business/Business Overview
    9.3 Chipscreen Biosciences Ltd
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Histone Deacetylase 1 Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Chipscreen Biosciences Ltd Histone Deacetylase 1 Sales, Revenue, Price and Gross Margin ()
        9.3.4 Main Business/Business Overview
    9.4 Curis, Inc.
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Histone Deacetylase 1 Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Curis, Inc. Histone Deacetylase 1 Sales, Revenue, Price and Gross Margin ()
        9.4.4 Main Business/Business Overview
    9.5 GlaxoSmithKline Plc
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Histone Deacetylase 1 Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 GlaxoSmithKline Plc Histone Deacetylase 1 Sales, Revenue, Price and Gross Margin ()
        9.5.4 Main Business/Business Overview
    9.6 HitGen LTD
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Histone Deacetylase 1 Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 HitGen LTD Histone Deacetylase 1 Sales, Revenue, Price and Gross Margin ()
        9.6.4 Main Business/Business Overview
    9.7 IRBM Science Park SpA
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Histone Deacetylase 1 Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 IRBM Science Park SpA Histone Deacetylase 1 Sales, Revenue, Price and Gross Margin ()
        9.7.4 Main Business/Business Overview
    9.8 Italfarmaco S.p.A.
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Histone Deacetylase 1 Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Italfarmaco S.p.A. Histone Deacetylase 1 Sales, Revenue, Price and Gross Margin ()
        9.8.4 Main Business/Business Overview
    9.9 MEI Pharma, Inc.
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Histone Deacetylase 1 Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 MEI Pharma, Inc. Histone Deacetylase 1 Sales, Revenue, Price and Gross Margin ()
        9.9.4 Main Business/Business Overview
    9.10 Merck & Co., Inc.
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Histone Deacetylase 1 Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 Merck & Co., Inc. Histone Deacetylase 1 Sales, Revenue, Price and Gross Margin ()
        9.10.4 Main Business/Business Overview
    9.11 Mirati Therapeutics Inc.
    9.12 Oncolys BioPharma Inc.
    9.13 Sigma-Tau S.p.A.
    9.14 Syndax Pharmaceuticals, Inc.
    9.15 TetraLogic Pharmaceuticals

10 Histone Deacetylase 1 Maufacturing Cost Analysis
    10.1 Histone Deacetylase 1 Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Histone Deacetylase 1
    10.3 Manufacturing Process Analysis of Histone Deacetylase 1

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Histone Deacetylase 1 Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Histone Deacetylase 1 Major Manufacturers in
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Histone Deacetylase 1 Market Forecast (2018-2025)
    14.1 Global Histone Deacetylase 1 Sales Volume, Revenue and Price Forecast (2018-2025)
       14.1.1 Global Histone Deacetylase 1 Sales Volume and Growth Rate Forecast (2018-2025)
       14.1.2 Global Histone Deacetylase 1 Revenue and Growth Rate Forecast (2018-2025)
       14.1.3 Global Histone Deacetylase 1 Price and Trend Forecast (2018-2025)
    14.2 Global Histone Deacetylase 1 Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
       14.2.1 Global Histone Deacetylase 1 Sales Volume and Growth Rate Forecast by Regions (2018-2025)
       14.2.2 Global Histone Deacetylase 1 Revenue and Growth Rate Forecast by Regions (2018-2025)
       14.2.3 United States Histone Deacetylase 1 Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.4 Europe Histone Deacetylase 1 Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.5 China Histone Deacetylase 1 Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.6 Japan Histone Deacetylase 1 Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.7 Southeast Asia Histone Deacetylase 1 Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.8 India Histone Deacetylase 1 Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
    14.3 Global Histone Deacetylase 1 Sales Volume, Revenue and Price Forecast by Type (2018-2025)
       14.3.1 Global Histone Deacetylase 1 Sales Forecast by Type (2018-2025)
       14.3.2 Global Histone Deacetylase 1 Revenue Forecast by Type (2018-2025)
       14.3.3 Global Histone Deacetylase 1 Price Forecast by Type (2018-2025)
    14.4 Global Histone Deacetylase 1 Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer
List of Tables and Figures

    Figure Product Picture of Histone Deacetylase 1
    Figure Global Histone Deacetylase 1 Sales Volume Comparison (K Pcs) by Type
    Figure Global Histone Deacetylase 1 Sales Volume Market Share by Type (Product Category) in
    Figure RCY-1305 Product Picture
    Figure HG-3001 Product Picture
    Figure CS-3158 Product Picture
    Figure ACY-957 Product Picture
    Figure ST-3595 Product Picture
    Figure Others Product Picture
    Figure Global Histone Deacetylase 1 Sales Comparison (K Pcs) by Application
    Figure Global Sales Market Share of Histone Deacetylase 1 by Application in
    Figure Alopecia Examples
    Table Key Downstream Customer in Alopecia
    Figure Endometrial Cancer Examples
    Table Key Downstream Customer in Endometrial Cancer
    Figure Myelofibrosis Examples
    Table Key Downstream Customer in Myelofibrosis
    Figure Neurology Examples
    Table Key Downstream Customer in Neurology
    Figure Skin Cancer Examples
    Table Key Downstream Customer in Skin Cancer
    Figure Others Examples
    Table Key Downstream Customer in Others
    Figure Global Histone Deacetylase 1 Market Size (Million USD) by Regions
    Figure United States Histone Deacetylase 1 Revenue (Million USD) and Growth Rate
    Figure Europe Histone Deacetylase 1 Revenue (Million USD) and Growth Rate
    Figure China Histone Deacetylase 1 Revenue (Million USD) and Growth Rate
    Figure Japan Histone Deacetylase 1 Revenue (Million USD) and Growth Rate
    Figure Southeast Asia Histone Deacetylase 1 Revenue (Million USD) and Growth Rate
    Figure India Histone Deacetylase 1 Revenue (Million USD) and Growth Rate
    Figure Global Histone Deacetylase 1 Sales Volume (K Pcs) and Growth Rate
    Figure Global Histone Deacetylase 1 Revenue (Million USD) and Growth Rate
    Figure Global Market Major Players Histone Deacetylase 1 Sales Volume (K Pcs) ()
    Table Global Histone Deacetylase 1 Sales (K Pcs) of Key Players/Suppliers ()
    Table Global Histone Deacetylase 1 Sales Share by Players/Suppliers ()
    Figure  Histone Deacetylase 1 Sales Share by Players/Suppliers
    Figure  Histone Deacetylase 1 Sales Share by Players/Suppliers
    Figure Global Histone Deacetylase 1 Revenue (Million USD) by Players/Suppliers ()
    Table Global Histone Deacetylase 1 Revenue (Million USD) by Players/Suppliers ()
    Table Global Histone Deacetylase 1 Revenue Share by Players/Suppliers ()
    Table  Global Histone Deacetylase 1 Revenue Share by Players
    Table  Global Histone Deacetylase 1 Revenue Share by Players
    Table Global Histone Deacetylase 1 Sales (K Pcs) and Market Share by Type ()
    Table Global Histone Deacetylase 1 Sales Share (K Pcs) by Type ()
    Figure Sales Market Share of Histone Deacetylase 1 by Type ()
    Figure Global Histone Deacetylase 1 Sales Growth Rate by Type ()
    Table Global Histone Deacetylase 1 Revenue (Million USD) and Market Share by Type ()
    Table Global Histone Deacetylase 1 Revenue Share by Type ()
    Figure Revenue Market Share of Histone Deacetylase 1 by Type ()
    Figure Global Histone Deacetylase 1 Revenue Growth Rate by Type ()
    Table Global Histone Deacetylase 1 Sales Volume (K Pcs) and Market Share by Region ()
    Table Global Histone Deacetylase 1 Sales Share by Region ()
    Figure Sales Market Share of Histone Deacetylase 1 by Region ()
    Figure Global Histone Deacetylase 1 Sales Growth Rate by Region in
    Table Global Histone Deacetylase 1 Revenue (Million USD) and Market Share by Region ()
    Table Global Histone Deacetylase 1 Revenue Share (%) by Region ()
    Figure Revenue Market Share of Histone Deacetylase 1 by Region ()
    Figure Global Histone Deacetylase 1 Revenue Growth Rate by Region in
    Table Global Histone Deacetylase 1 Revenue (Million USD) and Market Share by Region ()
    Table Global Histone Deacetylase 1 Revenue Share (%) by Region ()
    Figure Revenue Market Share of Histone Deacetylase 1 by Region ()
    Figure Global Histone Deacetylase 1 Revenue Market Share by Region in
    Table Global Histone Deacetylase 1 Sales Volume (K Pcs) and Market Share by Application ()
    Table Global Histone Deacetylase 1 Sales Share (%) by Application ()
    Figure Sales Market Share of Histone Deacetylase 1 by Application ()
    Figure Global Histone Deacetylase 1 Sales Market Share by Application ()
    Figure United States Histone Deacetylase 1 Sales (K Pcs) and Growth Rate ()
    Figure United States Histone Deacetylase 1 Revenue (Million USD) and Growth Rate ()
    Figure United States Histone Deacetylase 1 Sales Price (USD/Pcs) Trend ()
    Table United States Histone Deacetylase 1 Sales Volume (K Pcs) by Players ()
    Table United States Histone Deacetylase 1 Sales Volume Market Share by Players ()
    Figure United States Histone Deacetylase 1 Sales Volume Market Share by Players in
    Table United States Histone Deacetylase 1 Sales Volume (K Pcs) by Type ()
    Table United States Histone Deacetylase 1 Sales Volume Market Share by Type ()
    Figure United States Histone Deacetylase 1 Sales Volume Market Share by Type in
    Table United States Histone Deacetylase 1 Sales Volume (K Pcs) by Application ()
    Table United States Histone Deacetylase 1 Sales Volume Market Share by Application ()
    Figure United States Histone Deacetylase 1 Sales Volume Market Share by Application in
    Figure Europe Histone Deacetylase 1 Sales (K Pcs) and Growth Rate ()
    Figure Europe Histone Deacetylase 1 Revenue (Million USD) and Growth Rate ()
    Figure Europe Histone Deacetylase 1 Sales Price (USD/Pcs) Trend ()
    Table Europe Histone Deacetylase 1 Sales Volume (K Pcs) by Players ()
    Table Europe Histone Deacetylase 1 Sales Volume Market Share by Players ()
    Figure Europe Histone Deacetylase 1 Sales Volume Market Share by Players in
    Table Europe Histone Deacetylase 1 Sales Volume (K Pcs) by Type ()
    Table Europe Histone Deacetylase 1 Sales Volume Market Share by Type ()
    Figure Europe Histone Deacetylase 1 Sales Volume Market Share by Type in
    Table Europe Histone Deacetylase 1 Sales Volume (K Pcs) by Application ()
    Table Europe Histone Deacetylase 1 Sales Volume Market Share by Application ()
    Figure Europe Histone Deacetylase 1 Sales Volume Market Share by Application in
    Figure China Histone Deacetylase 1 Sales (K Pcs) and Growth Rate ()
    Figure China Histone Deacetylase 1 Revenue (Million USD) and Growth Rate ()
    Figure China Histone Deacetylase 1 Sales Price (USD/Pcs) Trend ()
    Table China Histone Deacetylase 1 Sales Volume (K Pcs) by Players ()
    Table China Histone Deacetylase 1 Sales Volume Market Share by Players ()
    Figure China Histone Deacetylase 1 Sales Volume Market Share by Players in
    Table China Histone Deacetylase 1 Sales Volume (K Pcs) by Type ()
    Table China Histone Deacetylase 1 Sales Volume Market Share by Type ()
    Figure China Histone Deacetylase 1 Sales Volume Market Share by Type in
    Table China Histone Deacetylase 1 Sales Volume (K Pcs) by Application ()
    Table China Histone Deacetylase 1 Sales Volume Market Share by Application ()
    Figure China Histone Deacetylase 1 Sales Volume Market Share by Application in
    Figure Japan Histone Deacetylase 1 Sales (K Pcs) and Growth Rate ()
    Figure Japan Histone Deacetylase 1 Revenue (Million USD) and Growth Rate ()
    Figure Japan Histone Deacetylase 1 Sales Price (USD/Pcs) Trend ()
    Table Japan Histone Deacetylase 1 Sales Volume (K Pcs) by Players ()
    Table Japan Histone Deacetylase 1 Sales Volume Market Share by Players ()
    Figure Japan Histone Deacetylase 1 Sales Volume Market Share by Players in
    Table Japan Histone Deacetylase 1 Sales Volume (K Pcs) by Type ()
    Table Japan Histone Deacetylase 1 Sales Volume Market Share by Type ()
    Figure Japan Histone Deacetylase 1 Sales Volume Market Share by Type in
    Table Japan Histone Deacetylase 1 Sales Volume (K Pcs) by Application ()
    Table Japan Histone Deacetylase 1 Sales Volume Market Share by Application ()
    Figure Japan Histone Deacetylase 1 Sales Volume Market Share by Application in
    Figure Southeast Asia Histone Deacetylase 1 Sales (K Pcs) and Growth Rate ()
    Figure Southeast Asia Histone Deacetylase 1 Revenue (Million USD) and Growth Rate ()
    Figure Southeast Asia Histone Deacetylase 1 Sales Price (USD/Pcs) Trend ()
    Table Southeast Asia Histone Deacetylase 1 Sales Volume (K Pcs) by Players ()
    Table Southeast Asia Histone Deacetylase 1 Sales Volume Market Share by Players ()
    Figure Southeast Asia Histone Deacetylase 1 Sales Volume Market Share by Players in
    Table Southeast Asia Histone Deacetylase 1 Sales Volume (K Pcs) by Type ()
    Table Southeast Asia Histone Deacetylase 1 Sales Volume Market Share by Type ()
    Figure Southeast Asia Histone Deacetylase 1 Sales Volume Market Share by Type in
    Table Southeast Asia Histone Deacetylase 1 Sales Volume (K Pcs) by Application ()
    Table Southeast Asia Histone Deacetylase 1 Sales Volume Market Share by Application ()
    Figure Southeast Asia Histone Deacetylase 1 Sales Volume Market Share by Application in
    Figure India Histone Deacetylase 1 Sales (K Pcs) and Growth Rate ()
    Figure India Histone Deacetylase 1 Revenue (Million USD) and Growth Rate ()
    Figure India Histone Deacetylase 1 Sales Price (USD/Pcs) Trend ()
    Table India Histone Deacetylase 1 Sales Volume (K Pcs) by Players ()
    Table India Histone Deacetylase 1 Sales Volume Market Share by Players ()
    Figure India Histone Deacetylase 1 Sales Volume Market Share by Players in
    Table India Histone Deacetylase 1 Sales Volume (K Pcs) by Type ()
    Table India Histone Deacetylase 1 Sales Volume Market Share by Type ()
    Figure India Histone Deacetylase 1 Sales Volume Market Share by Type in
    Table India Histone Deacetylase 1 Sales Volume (K Pcs) by Application ()
    Table India Histone Deacetylase 1 Sales Volume Market Share by Application ()
    Figure India Histone Deacetylase 1 Sales Volume Market Share by Application in
    Table 4SC AG Basic Information List
    Table 4SC AG Histone Deacetylase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ()
    Figure 4SC AG Histone Deacetylase 1 Sales Growth Rate ()
    Figure 4SC AG Histone Deacetylase 1 Sales Global Market Share ()
    Figure 4SC AG Histone Deacetylase 1 Revenue Global Market Share ()
    Table Acetylon Pharmaceuticals, Inc. Basic Information List
    Table Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ()
    Figure Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Sales Growth Rate ()
    Figure Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Sales Global Market Share ()
    Figure Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Revenue Global Market Share ()
    Table Chipscreen Biosciences Ltd Basic Information List
    Table Chipscreen Biosciences Ltd Histone Deacetylase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ()
    Figure Chipscreen Biosciences Ltd Histone Deacetylase 1 Sales Growth Rate ()
    Figure Chipscreen Biosciences Ltd Histone Deacetylase 1 Sales Global Market Share (
    Figure Chipscreen Biosciences Ltd Histone Deacetylase 1 Revenue Global Market Share ()
    Table Curis, Inc. Basic Information List
    Table Curis, Inc. Histone Deacetylase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ()
    Figure Curis, Inc. Histone Deacetylase 1 Sales Growth Rate ()
    Figure Curis, Inc. Histone Deacetylase 1 Sales Global Market Share ()
    Figure Curis, Inc. Histone Deacetylase 1 Revenue Global Market Share ()
    Table GlaxoSmithKline Plc Basic Information List
    Table GlaxoSmithKline Plc Histone Deacetylase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ()
    Figure GlaxoSmithKline Plc Histone Deacetylase 1 Sales Growth Rate ()
    Figure GlaxoSmithKline Plc Histone Deacetylase 1 Sales Global Market Share ()
    Figure GlaxoSmithKline Plc Histone Deacetylase 1 Revenue Global Market Share ()
    Table HitGen LTD Basic Information List
    Table HitGen LTD Histone Deacetylase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ()
    Figure HitGen LTD Histone Deacetylase 1 Sales Growth Rate ()
    Figure HitGen LTD Histone Deacetylase 1 Sales Global Market Share (
    Figure HitGen LTD Histone Deacetylase 1 Revenue Global Market Share ()
    Table IRBM Science Park SpA Basic Information List
    Table IRBM Science Park SpA Histone Deacetylase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ()
    Figure IRBM Science Park SpA Histone Deacetylase 1 Sales Growth Rate ()
    Figure IRBM Science Park SpA Histone Deacetylase 1 Sales Global Market Share ()
    Figure IRBM Science Park SpA Histone Deacetylase 1 Revenue Global Market Share ()
    Table Italfarmaco S.p.A. Basic Information List
    Table Italfarmaco S.p.A. Histone Deacetylase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ()
    Figure Italfarmaco S.p.A. Histone Deacetylase 1 Sales Growth Rate ()
    Figure Italfarmaco S.p.A. Histone Deacetylase 1 Sales Global Market Share (
    Figure Italfarmaco S.p.A. Histone Deacetylase 1 Revenue Global Market Share ()
    Table MEI Pharma, Inc. Basic Information List
    Table MEI Pharma, Inc. Histone Deacetylase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ()
    Figure MEI Pharma, Inc. Histone Deacetylase 1 Sales Growth Rate ()
    Figure MEI Pharma, Inc. Histone Deacetylase 1 Sales Global Market Share ()
    Figure MEI Pharma, Inc. Histone Deacetylase 1 Revenue Global Market Share ()
    Table Merck & Co., Inc. Basic Information List
    Table Merck & Co., Inc. Histone Deacetylase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ()
    Figure Merck & Co., Inc. Histone Deacetylase 1 Sales Growth Rate ()
    Figure Merck & Co., Inc. Histone Deacetylase 1 Sales Global Market Share ()
    Figure Merck & Co., Inc. Histone Deacetylase 1 Revenue Global Market Share ()
    Table Mirati Therapeutics Inc. Basic Information List
    Table Oncolys BioPharma Inc. Basic Information List
    Table Sigma-Tau S.p.A. Basic Information List
    Table Syndax Pharmaceuticals, Inc. Basic Information List
    Table TetraLogic Pharmaceuticals Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Histone Deacetylase 1
    Figure Manufacturing Process Analysis of Histone Deacetylase 1
    Figure Histone Deacetylase 1 Industrial Chain Analysis
    Table Raw Materials Sources of Histone Deacetylase 1 Major Players in
    Table Major Buyers of Histone Deacetylase 1
    Table Distributors/Traders List
    Figure Global Histone Deacetylase 1 Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
    Figure Global Histone Deacetylase 1 Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Global Histone Deacetylase 1 Price (USD/Pcs) and Trend Forecast (2018-2025)
    Table Global Histone Deacetylase 1 Sales Volume (K Pcs) Forecast by Regions (2018-2025)
    Figure Global Histone Deacetylase 1 Sales Volume Market Share Forecast by Regions (2018-2025)
    Figure Global Histone Deacetylase 1 Sales Volume Market Share Forecast by Regions in 2025
    Table Global Histone Deacetylase 1 Revenue (Million USD) Forecast by Regions (2018-2025)
    Figure Global Histone Deacetylase 1 Revenue Market Share Forecast by Regions (2018-2025)
    Figure Global Histone Deacetylase 1 Revenue Market Share Forecast by Regions in 2025
    Figure United States Histone Deacetylase 1 Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
    Figure United States Histone Deacetylase 1 Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Europe Histone Deacetylase 1 Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
    Figure Europe Histone Deacetylase 1 Revenue and Growth Rate Forecast (2018-2025)
    Figure China Histone Deacetylase 1 Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
    Figure China Histone Deacetylase 1 Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Japan Histone Deacetylase 1 Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
    Figure Japan Histone Deacetylase 1 Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Southeast Asia Histone Deacetylase 1 Sales Volu

Competitive Landscape – Key Market Players

The market is R&D-intensive and innovation-driven, dominated by pharmaceutical companies and biotech firms focusing on targeted epigenetic therapies.

Major Companies Profiled

  • 4SC AG

  • Acetylon Pharmaceuticals

  • Chipscreen Biosciences

  • Curis

  • GlaxoSmithKline

  • HitGen

  • IRBM Science Park

  • Italfarmaco

  • MEI Pharma

  • Merck & Co.

  • Mirati Therapeutics

  • Oncolys BioPharma

  • Sigma-Tau

  • Syndax Pharmaceuticals

  • TetraLogic Pharmaceuticals

Additional Emerging & Pipeline Participants

  • Selvita S.A.

  • Epizyme (epigenetics-focused oncology developer)

  • Beijing Kawin Technology

  • Ascentage Pharma

  • Haisco Pharmaceutical Group


Segmentation Analysis

By Product / Molecule Type

  • RCY-1305

  • HG-3001

  • CS-3158

  • ACY-957

  • ST-3595

  • Other HDAC1-Selective & Dual Inhibitors

Insight: Selective HDAC1 inhibitors are gaining preference over pan-HDAC inhibitors due to improved safety profiles and reduced off-target toxicity.


By Application

  • Alopecia

  • Endometrial Cancer

  • Myelofibrosis

  • Neurological Disorders

  • Skin Cancer

  • Other Oncological & Autoimmune Indications

Insight: Oncology applications account for the largest share, while neurology represents a high-growth emerging segment.

FAQ's

Yes, we are providing all research support to get resolve all queries and concerns regarding the report. For all our clients.
Yes, we are providing complete customization in every report to fulfill your business needs.
Yes, we are providing regional and countries level analysis in the report, please mention the countries you are looking.
Yes, we are providing a discount for individuals and startups.
We offer access to more than one million market research reports. If the specific topic you need is not listed on our website, simply email us your requirements at [email protected]. Our research team will review your request and provide a customized report or the most relevant available study. We

Similar Reports